Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
•
Colorectal Cancer
•
Liver and Pancreas Tumors
•
Hepatology & Liver Transplantation
•
Organ Transplantation
Would you offer HAI (hepatic arterial infusion) or Y90 for colorectal liver metastases as a bridge to transplant?
Related Questions
What are your top takeaways in GI Cancers from ASCO 2023?
What are best practices for oncologists during the national platinum shortage?
How would you approach a patient with clinical T3N1 anorectal malignant melanoma referred by a surgeon for neoadjuvant therapy?
Would you offer adjuvant chemotherapy or radiation to a resected MSS T3N0 high-rectal lesion with low anterior resection without pre-op therapy?
Would you recommend adjuvant capecitabine and radiation in addition to adjuvant FOLFOX for a patient with resected pT3N2 rectosigmoid adenocarcinoma with other high-risk pathologic features?
How do you sequence hypofractionated radiation and systemic therapy for patients with unresectable cholangiocarcinoma?
In patients with perianal squamous cell carcinoma extending to the vulva, would you cover the entire vulva or would generous margins on the gross disease suffice?
How would you alter your treatment volumes in a patient with distal esophageal cancer who has had prior gastric bypass surgery?
How would you sequence treatment of a synchronous IC1 high-grade serous ovarian cancer and cT3N1 rectal cancer?
How would you approach treating a patient who refuses surgery, but has significant residual disease after chemoradiotherapy for squamous cell carcinoma of the esophagus?